SYNTHON BIOPHARMACEUTICALS B.V.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07K PEPTIDES 8128
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6161
 
 
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0320,965 PAN-REACTIVE ANTIBODIES TO DUOCARMYCINSSep 22, 15Nov 09, 17[G01N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9890159 Process for making duocarmycin prodrugsJun 05, 14Feb 13, 18[C07D]
9845338 Method of purifying an antibodyJun 21, 12Dec 19, 17[C07K]
9702866 Glatiramer acetate human monocytic cell line-based potency assayApr 25, 14Jul 11, 17[G01N]
9580501 Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseasesDec 14, 12Feb 28, 17[A61K, C12N, C07K]
9573996 Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseasesDec 14, 12Feb 21, 17[A61K, C12N, C07K]
9427480 Duocarmycin ADCs for use in treatment of endometrial cancerSep 18, 15Aug 30, 16[A61K, C07D, C07K]
9421278 Duocarmycin ADCS showing improved in vivo antitumor activitySep 18, 15Aug 23, 16[A61K, C07D, C07K]
8716557 Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in plantsJan 17, 07May 06, 14[C07H, C12N, A01H]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0014,525 DUOCARMYCIN ADCS SHOWING IMPROVED IN VIVO ANTITUMOR ACTIVITYAbandonedJul 21, 16Jan 19, 17[A61K, C07K]
2014/0216,118 Compositions and Methods for Making and Biocontaining Auxotrophic Transgenic PlantsAbandonedJun 13, 12Aug 07, 14[C12N]
2012/0258,491 EXPRESSION OF BIOLOGICALLY ACTIVE POLYPEPTIDES IN DUCKWEEDAbandonedSep 14, 11Oct 11, 12[C12P, C12N, A01H]
2012/0220,015 COMPOSITIONS AND METHODS FOR PRODUCTION OF AGLYCOSYLATED PLASMINOGENAbandonedMay 26, 10Aug 30, 12[C12N, A01H]
2012/0190,004 METHODS AND COMPOSITIONS FOR THE CRYOPRESERVATION OF DUCKWEEDAbandonedJun 22, 10Jul 26, 12[A01N]
8182803 C-terminally truncated interferon alpha variantsExpiredMay 11, 11May 22, 12[A61K, C12P, C12N, C07K]
8034916 familyExpiredOct 19, 09Oct 11, 11[C07H, C12N, A01H]
8022270 Expression of biologically active polypeptides in duckweedExpiredSep 30, 03Sep 20, 11[C12N, A01H]
8017836 Expression of plasminogen and microplasminogen in duckweedExpiredDec 22, 09Sep 13, 11[C12N, A01H]
7959910 C-terminally truncated interferon alpha variantsExpiredApr 16, 04Jun 14, 11[A61K, C07H, C12P, C12N, C07K]
7884264 Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plantsExpiredJan 17, 07Feb 08, 11[C07H, C12N, A01H]
2010/0303,808 HUMANIZED ANTI-CD20 ANTIBODIES AND METHODS OF USEAbandonedMar 09, 10Dec 02, 10[A61K, C07H, C12N, A61P, C07K]
2010/0209,966 ASEPTIC BIOREACTOR SYSTEM FOR PROCESSING BIOLOGICAL MATERIALSAbandonedFeb 18, 10Aug 19, 10[C12P, C12M]
7709699 Use of duckweed in high throughput screeningExpiredMay 30, 02May 04, 10[C12N, B01L, A01H]
7659445 Expression of plasminogen and microplasminogen in duck weedExpiredFeb 11, 05Feb 09, 10[C12N]
7632983 Expression of monoclonal antibodies in duckweedExpiredMar 05, 04Dec 15, 09[C12N, A01H]
7622573 Expression control elements from the lemnaceae familyExpiredJan 16, 07Nov 24, 09[C07H, C12N, A01H]
2009/0060,921 GLYCAN-OPTIMIZED ANTI-CD20 ANTIBODIESAbandonedMay 05, 08Mar 05, 09[A61K, C12N, A61P, C07K]
7326385 Plate and method for high throughput screeningExpiredMay 29, 02Feb 05, 08[B01L]
7311912 Epithelial tissue targeting agentExpiredJan 09, 98Dec 25, 07[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.